
DBV Technologies S.A. DBVT
€ 8.86
-2.07%
Land |
|
IPO-Jahr |
2014 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
140 M |
Marktkapitalisierung |
$ 1.39 B |
EBITDA (LTM) |
$ -144 M |
P/E (LTM) |
-10.152381 |
P/S (LTM) |
263.992477 |
EPS (LTM) |
-1.05 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Sol-Gel Technologies Ltd.
SLGL
|
$ 66.7 | 4.53 % | $ 186 M | Nasdaq Global Select Market | ||
|
SELLAS Life Sciences Group
SLS
|
$ 9.15 | 3.1 % | $ 998 M | Nasdaq Capital Market | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | ||
|
Syndax Pharmaceuticals
SNDX
|
$ 10.48 | -26.94 % | $ 908 M | Nasdaq Global Select Market | ||
|
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | ||
|
Sanofi
SNY
|
$ 47.45 | 4.67 % | $ 57.9 B | Nasdaq Global Select Market | ||
|
CNS Pharmaceuticals
CNSP
|
$ 4.21 | -7.47 % | $ 1.87 M | Nasdaq Capital Market | ||
|
Spero Therapeutics
SPRO
|
$ 1.07 | 2.88 % | $ 59.9 M | Nasdaq Global Select Market | ||
|
DiaMedica Therapeutics
DMAC
|
$ 10.79 | 7.85 % | $ 507 M | Nasdaq Capital Market | ||
|
Sarepta Therapeutics
SRPT
|
$ 18.97 | 2.32 % | $ 1.9 B | Nasdaq Global Select Market,SPB | ||
|
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | ||
|
Takeda Pharmaceutical Company Limited
TAK
|
$ 21.07 | 1.52 % | $ 33.3 B | NYSE | ||
|
Tarsus Pharmaceuticals
TARS
|
$ 69.01 | -5.0 % | $ 2.88 B | Nasdaq Global Select Market | ||
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | ||
|
Bio-Techne Corporation
TECH
|
$ 72.8 | 0.19 % | $ 11.4 B | Nasdaq Global Select Market,SPB | ||
|
Teva Pharmaceutical Industries Limited
TEVA
|
$ 41.97 | 0.14 % | $ 48.1 B | NYSE | ||
|
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | ||
|
Precision BioSciences
DTIL
|
$ 8.01 | 14.92 % | $ 103 M | Nasdaq Global Select Market | ||
|
BioXcel Therapeutics
BTAI
|
$ 0.07 | 9.81 % | $ 855 K | Nasdaq Global Select Market,SPB | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 5.12 | -1.45 % | $ 43.6 M | Nasdaq Global Select Market | ||
|
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | ||
|
Taysha Gene Therapies
TSHA
|
$ 4.34 | 5.99 % | $ 1.39 B | Nasdaq Global Select Market | ||
|
NeuBase Therapeutics
NBSE
|
- | -1.56 % | $ 12.3 M | Nasdaq Global Select Market | ||
|
Citius Pharmaceuticals
CTXR
|
$ 0.56 | -2.77 % | $ 6.2 M | Nasdaq Capital Market | ||
|
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | ||
|
Arena Pharmaceuticals
ARNA
|
- | -6.81 % | $ 3.04 B | Nasdaq Global Select Market,SPB | ||
|
Scopus BioPharma
SCPS
|
- | -48.37 % | $ 3.71 M | Nasdaq Global Select Market | ||
|
Annovis Bio
ANVS
|
$ 1.2 | 9.63 % | $ 24.7 M | NYSE American | ||
|
United Therapeutics Corporation
UTHR
|
$ 608.19 | 1.14 % | $ 26.9 B | Nasdaq Global Select Market,SPB | ||
|
scPharmaceuticals
SCPH
|
- | - | $ 218 M | Nasdaq Global Select Market | ||
|
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | ||
|
Vericel Corporation
VCEL
|
$ 45.83 | 11.54 % | $ 2.31 B | Nasdaq Global Select Market,SPB | ||
|
Athersys
ATHX
|
- | 3.77 % | $ 22.4 M | Nasdaq Capital Market | ||
|
Veracyte
VCYT
|
$ 52.31 | 4.02 % | $ 4.11 B | Nasdaq Global Market,SPB | ||
|
Exelixis
EXEL
|
$ 72.73 | 0.58 % | $ 19.8 B | Nasdaq Global Select Market,SPB | ||
|
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | ||
|
Vir Biotechnology
VIR
|
$ 11.67 | 4.01 % | $ 1.62 B | Nasdaq Global Select Market,SPB | ||
|
Viking Therapeutics
VKTX
|
$ 27.96 | 7.17 % | $ 3.15 B | Nasdaq Capital Market | ||
|
Vanda Pharmaceuticals
VNDA
|
$ 3.87 | 3.07 % | $ 228 M | Nasdaq Global Select Market,SPB | ||
|
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | ||
|
Verrica Pharmaceuticals
VRCA
|
$ 3.45 | 4.86 % | $ 36.8 M | Nasdaq Global Market | ||
|
Viridian Therapeutics
VRDN
|
$ 29.04 | 15.47 % | $ 2.96 B | Nasdaq Capital Market | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 549.04 | 3.44 % | $ 140 B | Nasdaq Global Select Market,SPB | ||
|
vTv Therapeutics
VTVT
|
$ 23.99 | 1.87 % | $ 94.9 M | Nasdaq Global Select Market | ||
|
Voyager Therapeutics
VYGR
|
$ 1.88 | 2.46 % | $ 110 M | Nasdaq Global Select Market | ||
|
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | ||
|
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | ||
|
Humanigen
HGEN
|
- | -81.12 % | $ 4.28 M | Nasdaq Global Select Market | ||
|
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | ||
|
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market |